Skin manifestations in patients with covid-19: A literature review
DOI:
https://doi.org/10.30659/sainsmed.v13i1.15563Keywords:
Cutaneous, Skin, Manifestation, COVID-19Abstract
Coronavirus disease (COVID-19) is an infectious disease caused by the SARS-CoV-2 virus. In December 2019, cases of pneumonia with unknown cause were first reported in Wuhan, Hubei Province, China. Confirmed cases and death rates due to COVID-19 in the world are still increasing. One part of the body that is affected and causes clinical symptoms in COVID-19 is the skin. This review aims to describe and analyze cutaneous manifestation in COVID-19. This study method is a review of the literature sourced from Google Scholar and PubMed. The literature was selected using English language criteria, using the clinical study method in the form of case reports. Meanwhile, literature review, systematic literature, and meta-analysis were excluded. Journal searches were carried out using the keywords "skin" OR "cutaneous" AND "manifestation" AND "COVID-19" OR "coronavirus". The skin manifestations of COVID-19 have been observed. The most common clinical symptoms of COVID-19 were fever (47%), dry or productive cough (25%), sore throat (16%), generalized sore throat (6%), and pain (5%). However, currently there has been a shift in the approach to diagnosing COVID-19 because it can cause symptoms in other organ systems, one of which is skin manifestations. There are early reports of skin involvement (erythematous rash, extensive urticaria, and chickenpox-like vesicles) occurring in 20% of patients in the course of the COVID-19 disease. In addition, several case reports provide descriptions of petechiae and chilblains. Based on the cases that have been reported, patients with COVID-19 who have manifestations on the skin can give a picture of maculopapular eruptions, vesicular eruptions, petechiae, and also childblains.
References
Bursal Duramaz, B., Yozgat, C.Y., Yozgat, Y. and Turel, O. (2020). Appearance of skin rash in pediatric patients with COVID-19: Three case presentations. Dermatologic Therapy, 33(4): 2–3. doi:10.1111/dth.13594.
Català , A, Galván-Casas, C, Carretero-Hernández, G, et al. (2020). Maculopapular eruptions associated to COVID-19: A subanalysis of the COVID-Piel study. Dermatologic Therapy, 33(6): 1–10. doi:10.1111/dth.14170.
Chen, Y., Liu, Q. and Guo, D. (2020). Emerging coronaviruses: Genome structure, replication, and pathogenesis. Journal of Medical Virology. 92(4): 418–423. doi:10.1002/jmv.25681.
Covid19.who.int. 2021. WHO Coronavirus (COVID-19) Dashboard. [online] Available at: <https://covid19.who.int/> [Accessed 12 March 2021].
Criado, P.R., Abdalla, B.M.Z., de Assis, I.C., van Blarcum de Graaff Mello C, Caputo GC, Vieira IC.. (2020). Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms. Inflammation Research. 69(8): 745–756. doi:10.1007/s00011-020-01370-w.
Diaz-Guimaraens, B, Dominguez-Santas, M, Suarez-Valle, A, et al. (2020). Petechial Skin Rash Associated with Severe Acute Respiratory Syndrome Coronavirus 2 Infection. JAMA Dermatology, 156(7): 820–822. doi:10.1001/jamadermatol.2020.1741.
Fernandez-Nieto, D., Ortega-Quijano, D., Jimenez-Cauhe, J., Burgos-Blasco, P., de Perosanz-Lobo, D., Suarez-Valle, A., Cortes-Cuevas, J.L., Carretero, I., Garcia-Del Real, C. and Fernandez-Guarino, M. (2020). Clinical and histological characterization of vesicular COVID-19 rashes: a prospective study in a tertiary care hospital. Clinical and Experimental Dermatology, 45(7), pp. 872–875. doi:10.1111/ced.14277.
Fernandez-Nieto, D., Ortega-Quijano, D., Jimenez-Cauhe, J., Burgos-Blasco, P., de Perosanz-Lobo, D., Suarez-Valle, A., Cortes-Cuevas, J.L., Carretero, I., Garcia-Del Real, C. and Fernandez-Guarino, M. (2020). Clinical Characteristics of Coronavirus Disease 2019 in China. New England Journal of Medicine, 382(18): 1708–1720. doi:10.1056/nejmoa2002032.
Freeman, E.E., McMahon, D.E., Lipoff, J.B., Rosenbach, M., Kovarik, C., Desai, S.R., Harp, J., Takeshita, J., French, L.E., Lim, H.W., Thiers, B.H., Hruza, G.J, Fox LP. (2020). The spectrum of COVID-19–associated dermatologic manifestations: An international registry of 716 patients from 31 countries. Journal of the American Academy of Dermatology, 83(4), pp. 1118–1129. doi:10.1016/j.jaad.2020.06.1016.
Gianotti, R., Zerbi, P. and Dodiuk-Gad, R.P. (2020) “Clinical and histopathological study of skin dermatoses in patients affected by COVID-19 infection in the Northern part of Italy,†Journal of Dermatological Science, 98(2): 141–143. doi:10.1016/j.jdermsci.2020.04.007.
Gottlieb, M. and Long, B. (2020). Dermatologic manifestations and complications of COVID-19. American Journal of Emergency Medicine, 38(9): 1715–1721. doi:10.1016/j.ajem.2020.06.011.
Hunt, M. and Koziatek, C. (2020). A Case of COVID-19 Pneumonia in a Young Male with Full Body Rash as a Presenting Symptom. Clinical Practice and Cases in Emergency Medicine, 4(2):0–3. doi:10.5811/cpcem.2020.3.47349.
Infeksiemerging.kemkes.go.id. 2021. Infeksi Emerging Kementerian Kesehatan RI. [online] Available at: <https://infeksiemerging.kemkes.go.id/dashboard/covid-19> [Accessed 12 March 2021].
Joob, B. and Wiwanitkit, V. (2020). COVID-19 can present with a rash and be mistaken for dengue. Journal of the American Academy of Dermatology, 82(5): e177. doi:10.1016/j.jaad.2020.03.036.
Landa, N., Mendieta-Eckert, M., Fonda-Pascual, P. and Aguirre, T.. (2020). Chilblain-like lesions on feet and hands during the COVID-19 Pandemic. International Journal of Dermatology, 59(6): 739–743. doi:10.1111/ijd.14937.
Lim, S.Y.D. and Tey, H.L. (2020). Response to ‘Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases’: vesicular eruption in COVID-19 – to exclude varicella, British Journal of Dermatology, 183(4): 790–791. doi:10.1111/bjd.19347.
Liu, J, Zheng, X, Tong, Q. (2020). Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV. Journal of Medical Virology., 92 : 491–494. doi:10.1002/jmv.25709.
Moreno R.A, Estela Villa LM., Avellana Moreno V., Estela Villa C., Moreno Aparicio MA., Avellana Fontanella JA. (2020). Cutaneous manifestation of COVID-19 in images: a case report. Journal of the European Academy of Dermatology and Venereology. 34(7): e307–e309. doi:10.1111/jdv.16531.
Murt, A., Eskazan, A.E., Yılmaz, U., Ozkan, T. and Ar, M.C. (2021). COVID-19 presenting with immune thrombocytopenia: A case report and review of the literature. Journal of Medical Virology, 93(1): 43–45. doi:10.1002/jmv.26138.
Nurulain T. Zaveri (2016). ä¹³é¼ å¿ƒè‚Œæå– HHS Public Access. Physiology & behavior, 176(10): 139–148. doi:10.1146/annurev-immunol-051116-052331.Intracellular.
Ortega-Quijano, D, Jimenez-Cauhe, J, Selda-Enriquez,G, Fernandez-Guarino, M, Fernandez-Nieto D.. et al. (2020) Algorithm for the classification of COVID-19 rashes. Journal of the American Academy of Dermatology, 83(2):
Prompetchara, E., Ketloy, C. and Palaga, T. (2020). IImmune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic. Asian Pacific Journal of Allergy and Immunology, 38(1):1–9. doi:10.12932/AP-200220-0772.
Suchonwanit, P., Leerunyakul, K. and Kositkuljorn, C. (2020). Diagnostic and prognostic values of cutaneous manifestations in COVID-19. Dermatologic Therapy. doi:10.1111/dth.13650.
Torres, T. and Puig, L. (2020). Managing Cutaneous Immune-Mediated Diseases During the COVID-19 Pandemic,†American Journal of Clinical Dermatology, 21(3), pp. 307–311. doi:10.1007/s40257-020-00514-2.
Vesely, M.D. and Perkins, S.H. (2020). Caution in the time of rashes and COVID-19. Journal of the American Academy of Dermatology, 83(4): e321–e322. doi:10.1016/j.jaad.2020.07.026.
Downloads
Published
Issue
Section
License
Journal Author(s) Rights
To publish and disseminate research articles, Sains Medika: Jurnal Kedokteran dan Kesehatan requires non-exclusive publishing rights (transferred from author(s) to publisher). This is determined by a publishing agreement between the Author(s) and Sains Med. J. Kedokt. dan Kesehat. This agreement governs with the transfer or license of the copyright of publishing to Sains Med. J. Kedokt. dan Kesehat, while Authors still retain significant rights to use and share their own published articles. Sains Med. J. Kedokt. dan Kesehat supports the need for authors to share, disseminate and maximize the impact of their research and these rights, in any databases.
As a journal Author, you have rights for a wide variety of uses of your article, including use by your institution or company of employment. These Author rights can be exercised without the need to obtain specific permission. Authors publishing in Sains Med. J. Kedokt. dan Kesehat have wide rights to use their works for teaching and scholarly purposes without needing to seek permission, including:
- Use for classroom teaching by Author or Author's institution and presentation at a meeting or conference and distributing copies to attendees;
- Use for internal training by author's company;
- Distribution to colleagues for their research use;
- Use in a subsequent compilation of the author's works;
- Inclusion in a thesis or dissertation;
- Reuse of portions or extracts from the article in other works (with full acknowledgement of final article);
- Preparation of derivative works (other than commercial purposes) (with full acknowledgement of final article);
- Voluntary posting on open web sites operated by author or author's institution for scholarly purposes,
Authors/Readers/Third Parties can copy and redistribute the material in any medium or format, as well as remix, transform, and build upon the material for any purpose, including commercial purposes, but they must give appropriate credit (the name of the creator and attribution parties (authors detail information), a copyright notice, an open access license notice, a disclaimer notice, and a link to the material), provide a link to the license, and indicate if changes were made (Publisher indicates the modification of the material (if any) and retain an indication of previous modifications using a CrossMark Policy and information about Erratum-Corrigendum notification).
Authors/Readers/Third Parties can read, print and download, redistribute or republish the article (e.g. display in a repository), translate the article, download for text and data mining purposes, reuse portions or extracts from the article in other works, sell or re-use for commercial purposes, remix, transform, or build upon the material, they must distribute their contributions under the same license as the original Creative Commons Attribution (CC BY).
Copyright Transfer Agreement for Publishing (Publishing Right)
The Authors submitting a manuscript do so on the understanding that if accepted for publication, the non-exclusive right for publishing (publishing right) of the article shall be assigned/transferred to the Publisher of Sains Medika: Jurnal Kedokteran dan Kesehatan and Faculty of Medicine Universitas Islam Sultan Agung (FK UNISSULA).
Upon acceptance of an article, authors will be required to complete a 'Copyright Transfer Agreement for Publishing (CTAP)'. An e-mail will be sent to the Corresponding Author confirming receipt of the manuscript together with a 'Copyright Transfer Agreement for Publishing' form by online version of this agreement.
Sains Medika: Jurnal Kedokteran dan Kesehatan and Faculty of Medicine Universitas Islam Sultan Agung (FK UNISSULA), the Editors and the Advisory International Editorial Board make every effort to ensure that incorrect or misleading data, opinions or statements be published in the journal. In any way, the contents of the articles and advertisements published in the Sains Medika: Jurnal Kedokteran dan Kesehatan are sole and exclusive responsibility of their respective authors and advertisers.
Remember, even though we ask for a transfer of copyright for publishing (CTAP), our journal Author(s) retain (or are granted back) significant scholarly rights as mentioned before.
The Copyright Transfer Agreement for Publishing (CTAP) Form can be downloaded here: [Copyright Transfer Agreement for Publishing (CTAP) Form Sains Medika 2022]
The copyright form must be electronically signed and emailed to the Editorial Office in the original form below:
Dr. Suparmi, S.Si, M.Si (ERT) (Editor-in-Chief)
Editorial Office of Sains Medika: Jurnal Kedokteran dan Kesehatan
Gedung Dekanat Lantai 1 Fakultas Kedokteran Universitas Islam Sultan Agung
Jl. Raya Kaligawe KM 4 Semarang 50112, Central Java, Indonesia
Telp/Whatsapp: +62 812-2993-3369
E-mail: sainsmedika@unissula.ac.id
(This policy statements has been updated 19 October 2022)
What is Crossmark?
CrossMark, a multi-publisher initiative from CrossRef, provides a standard way for readers to locate the authoritative version of a document. Sains Medika: Jurnal Kedokteran dan Kesehatan acknowledges the significance of the integrity and completeness of the scholarly record to scholars and librarians, and places the utmost importance on preserving the credibility of its electronic archive. Clicking on the CrossMark icon will inform the reader of a document's current status and may provide additional publication record information.





